Peter Voorhees, MD, explains how daratumumab and hyaluronidase-fihj show superior efficacy in delaying progression of MM compared with active monitoring.
Peter Voorhees, MD
Advertisement
Articles by Peter Voorhees, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
WHO Publishes GLP-1 Guidelines for Obesity Treatment
2
Frameworks for Advancing Health Equity: Dental Health Care Access
3
Olomorasib Showed Promising Antitumor Activity in NSCLC
4
Fee-for-Service Models Linked to Higher Odds of Low-Value Surgical Procedures
5
